Table 9.
Total Side Effects for Morphine and Pentazocine as a Function of Cycle Phase*
| NOC women (n=14) | OC women (n=17) | |||
|---|---|---|---|---|
| Follicular | Luteal | Follicular | Luteal | |
| Morphinea,b,c | 1.79 (1.19) | 0.79 (0.89) | 0.88 (0.93) | 0.94 (1.09) |
| Pentazocine | 1.5 (1.83) | 1.36 (1.5) | 1.76 (1.71) | 1.47 (1.70) |
NOC women showed significantly more morphine side-effects during the follicular phase versus the luteal phase [F(1,13=7.0, p = .02].
a
Phase p<0.05,
b
Oral Contraceptive group p>0.05,
c
Phase X Oral Contraceptive group p<0.05.
Bold shows that the interaction was driven by significantly greater side effects in the follicular vs. luteal phase for NOC but not OC women. p<0.05